| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum protein kinase inhibitor, suppressing various signaling pathways including those associated with A33, potentially inhibiting downstream targets and leading to the suppression of A33 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits phosphoinositide 3-kinases (PI3K), disrupting PI3K/Akt signaling pathway, which can indirectly down-regulate A33 expression or activity by interfering with the associated intracellular signaling cascades. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another inhibitor of PI3K, disrupting PI3K/Akt signaling pathway, which may indirectly suppress A33 expression or activity by interrupting the associated intracellular signaling cascades. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
A selective inhibitor of Akt, blocking Akt-mediated signaling pathways, potentially leading to the inhibition of downstream targets including A33. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
Inhibits Akt, a key player in the PI3K/Akt signaling pathway, which can indirectly affect A33 expression or activity by disrupting downstream signaling events involved in its regulation. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $173.00 $230.00 $275.00 $332.00 | 9 | |
A pan-class I PI3K inhibitor, targeting PI3K isoforms, and thereby disrupting PI3K/Akt signaling pathway, which may indirectly suppress A33 expression or activity by interfering with the associated intracellular signaling cascades. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $204.00 $265.00 | 29 | |
A potent Akt inhibitor, blocking Akt-mediated signaling pathways, which could lead to the inhibition of downstream targets including A33. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $32.00 $128.00 | 3 | |
A dual PI3K/mTOR inhibitor, blocking PI3K/Akt/mTOR signaling pathway, which can indirectly affect A33 expression or activity by interrupting the associated intracellular signaling cascades. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $184.00 $195.00 | 2 | |
Inhibits PI3K, disrupting PI3K/Akt signaling pathway, potentially leading to the suppression of downstream targets including A33. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a downstream effector in the PI3K/Akt signaling pathway, which may indirectly down-regulate A33 expression or activity by interfering with the mTOR-dependent regulation of protein synthesis and cell growth. | ||||||